0000905729-25-000168.txt : 20251008
0000905729-25-000168.hdr.sgml : 20251008
20251008153738
ACCESSION NUMBER: 0000905729-25-000168
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20251008
DATE AS OF CHANGE: 20251008
EFFECTIVENESS DATE: 20251008
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cirius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001702956
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 820928811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-560203
FILM NUMBER: 251382254
BUSINESS ADDRESS:
STREET 1: 3133 ORCHARD VISTA DR. SW
CITY: GRAND RAPIDS
STATE: MI
ZIP: 49546
BUSINESS PHONE: 616-450-5552
MAIL ADDRESS:
STREET 1: 3133 ORCHARD VISTA DR. SW
CITY: GRAND RAPIDS
STATE: MI
ZIP: 49546
D
1
primary_doc.xml
X0708
D
LIVE
0001702956
Cirius Therapeutics, Inc.
3133 ORCHARD VISTA DR. SW
GRAND RAPIDS
MI
MICHIGAN
49546
616-450-5552
DELAWARE
None
None
Corporation
true
Robert
A
Beardsley
3133 Orchard Vista Drive SW
Grand Rapids
MI
MICHIGAN
49546
Executive Officer
Jerry
Callahan
3133 Orchard Vista Drive SW
Grand Rapids
MI
MICHIGAN
49546
Executive Officer
Michael
Jandernoa
3133 Orchard Vista Drive SW
Grand Rapids
MI
MICHIGAN
49546
Director
David
Van Andel
3133 Orchard Vista Drive SW
Grand Rapids
MI
MICHIGAN
49546
Director
Robert
Zerbe
3133 Orchard Vista Drive SW
Grand Rapids
MI
MICHIGAN
49546
Director
Biotechnology
Decline to Disclose
- 06b
false
2025-10-07
true
true
true
false
0
1200000
800000
400000
false
22
0
0
0
false
Cirius Therapeutics, Inc.
/s/ Robert A. Beardsley
Robert A. Beardsley
President & CEO
2025-10-07